Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
Clinical trial NCT03197506 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03197506
- Sponsor
- Mayo Clinic
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-15
- Primary completion
- 2024-07-16
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.